Wenyi Wu
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Ocular Oncology and Treatments
-
- CRISPR and Genetic Engineering
- Retinal Development and Disorders
- RNA Interference and Gene Delivery
Papers in
-
- Retinal Development and Disorders 10
- CRISPR and Genetic Engineering 10
- Angiogenesis and VEGF in Cancer 2
-
- Retinal Diseases and Treatments 10
- Co-authors
- Hetian Lei (23 shared papers)Patrìcia A. D'Amore (6 shared papers)Gaoen Ma (9 shared papers)Xionggao Huang (7 shared papers)Jingyuan Song (3 shared papers)Luk H. Vandenberghe (2 shared papers)Feng Zhang (2 shared papers)Ru Xiao (1 shared paper)
- Journals
- Investigative Ophthalmology & Visual Science (4 papers)Experimental Eye Research (3 papers)The FASEB Journal (3 papers)Frontiers in Medicine (2 papers)Methods (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wenyi Wu
36 papers receiving 545 citations
Peers
Comparison fields: 5 of 67
- Ophthalmology 148
- Molecular Biology 313
- Radiology, Nuclear Medicine and Imaging 88
- Business and International Management 6
- Cancer Research 39
Countries citing papers authored by Wenyi Wu
This map shows the geographic impact of Wenyi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyi Wu more than expected).
Fields of papers citing papers by Wenyi Wu
This network shows the impact of papers produced by Wenyi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyi Wu. The network helps show where Wenyi Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenyi Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 120 | |
| 2 | 2017 | 53 | |
| 3 | 2017 | 36 | |
| 4 | 2014 | 34 | |
| 5 | 2022 | 31 | |
| 6 | 2020 | 29 | |
| 7 | Genome editing abrogates angiogenesis in vivo | 2017 | 28 |
| 8 | 2018 | 22 | |
| 9 | 2013 | 18 | |
| 10 | 2022 | 17 | |
| 11 | 2023 | 16 | |
| 12 | 2017 | 16 | |
| 13 | 2018 | 14 | |
| 14 | 2017 | 12 | |
| 15 | The role of netrin-1 in angiogenesis and diabetic retinopathy: a promising therapeutic strategy. | 2017 | 11 |
| 16 | 2023 | 10 | |
| 17 | 2020 | 9 | |
| 18 | 2019 | 8 | |
| 19 | 2020 | 8 | |
| 20 | 2021 | 7 |
About Wenyi Wu
Wenyi Wu is a scholar working on Molecular Biology, Ophthalmology, Radiology, Nuclear Medicine and Imaging, Immunology and Cellular and Molecular Neuroscience, having authored 39 papers that have together received 549 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (10 papers), Retinal Development and Disorders (10 papers), CRISPR and Genetic Engineering (10 papers), Retinal and Macular Surgery (7 papers), Retinal Imaging and Analysis (2 papers), interferon and immune responses (2 papers), Axon Guidance and Neuronal Signaling (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Ophthalmology (148 citations), Molecular Biology (313 citations), Radiology, Nuclear Medicine and Imaging (88 citations), Business and International Management (6 citations) and Cancer Research (39 citations). Wenyi Wu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Hetian Lei, Patrìcia A. D'Amore, Gaoen Ma, Xionggao Huang, Jingyuan Song, Luk H. Vandenberghe, Feng Zhang, Ru Xiao, Shizuo Mukai and Yanhui Yang. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Experimental Eye Research, The FASEB Journal, Frontiers in Medicine and Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.